Julie Dove

Julie Dove joined Galileo Pharmaceuticals, Inc. in March 2002 and currently serves as Director of Finance and Accounting.
Prior to Galileo Pharmaceuticals, she was an Assistant Controller at OmniSky Corp.
Prior to OmniSky, Ms. Dove was Financial Reporting Group Leader for the Vascular Intervention Division of Guidant Corp.
Previously, she was a Senior Auditor of Ernst & Young LLP.
Ms. Dove received a BS degree in Accounting from Saint Mary-of-the-Woods College.
She is a Certified Public Accountant.